Smad1-Smad5 Ovarian Conditional Knockout Mice Develop a Disease Profile Similar to the Juvenile Form of Human Granulosa Cell Tumors
Open Access
- 9 October 2009
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (12) , 5208-5217
Abstract
Granulosa cell tumors (GCTs) of the ovary are rare sex cord stromal tumors. Although generally indolent, GCTs recur, and if not diagnosed and treated in early stages, survival rates are significantly shortened. Very little is known regarding GCT etiology. Because of the low incidence of cases and lack of standard diagnostics, mouse models for granulosa cell tumors are a valuable tool for studying GCTs and provide models for developing diagnostic and treatment strategies. We recently developed a novel mouse model of metastatic granulosa cell tumors by genetic deletion of the bone morphogenetic protein signaling transcription factors (SMADs) in granulosa cells of the ovary. Histological and serum hormone analyses reveal that this mouse model most closely resembles the juvenile form of GCT. We further analyzed samples of human juvenile GCT (JGCT) for expression of anti-Müllerian hormone and activation of two major signaling pathways: TGFβ/SMAD2/3 and wingless-related mouse mammary tumor virus integration site (Wnt)/β-catenin. The TGFβ family is active in mouse Smad1-Smad5 double knockout tumors, and here we show that this pathway, but not the β-catenin pathway, is activated in samples of human JGCT. These data suggest that the SMAD family, possibly through disruption of SMAD1/5 or activation of SMAD2/3 may contribute to the pathogenesis of JGCT in humans.Keywords
This publication has 57 references indexed in Scilit:
- Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in MiceMolecular and Cellular Biology, 2008
- Granulosa cell tumor associated with secondary amenorrhea and serum luteinizing hormone elevationInternational Journal of Clinical Oncology, 2007
- Granulosa cell tumors of the ovary: The clinical value of serum inhibin A and B levels in a large single center cohortGynecologic Oncology, 2007
- Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancerProceedings of the National Academy of Sciences, 2006
- Distal Chr 4 Harbors a Genetic Locus (Gct1) Fundamental for Spontaneous Ovarian Granulosa Cell Tumorigenesis in a Mouse ModelCancer Research, 2005
- Inhibins and ovarian cancerMolecular and Cellular Endocrinology, 2004
- Inhibin Subunit Gene Expression in Ovarian CancerGynecologic Oncology, 1999
- Müllerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalitiesJournal of Pediatric Surgery, 1993
- Müllerian Inhibiting Substance as a Marker for Ovarian Sex-Cord TumorNew England Journal of Medicine, 1992
- Inhibin as a Marker for Granulosa-Cell TumorsNew England Journal of Medicine, 1989